In a MASH mouse model, a ten-week IF intervention significantly reduced body weight, energy intake, and epididymal fat percentage, while alleviating hepatic steatosis, ballooning degeneration, lobular inflammation, NAFLD activity score, and insulin resistance [21]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.